Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jeffrey Edwards, Arnold Pinkston, Gregory Hinckley, and more

Jeffrey Edwards, Arnold Pinkston, Gregory Hinckley

Bio-Rad has elected three new board members — Jeffrey Edwards, Gregory Hinckley, and Arnold Pinkston — at its annual shareholders meeting.

Jeffrey Edwards previously served as CEO of Allergan from 2005 to August 2014, and retired from the company in 2015 after 22 years.

Arnold Pinkston previously served as executive vice president and general counsel for Allergan, senior vice president and general counsel for Beckman Coulter, and vice president and deputy general counsel at Eli Lilly.

Gregory Hinckley currently serves as president of Mentor Graphics, a supplier of products and services used for the design of electronic content, and has 30 years of public company experience.

The newly-elected members replace Louis Drapeau, Robert Malchione, Joel McComb, and Deborah Neff, who declined to stand for reelection due to disagreements with Bio-Rad's management regarding executive personnel and corporate governance matters, according to a Securities and Exchange Commission filing. In a statement, Bio-Rad noted that their decision not to stand for reelection was not related to any issues regarding the integrity of the company's financial statements or accounting policies and practices.


Madhuri Hegde

PerkinElmer has appointed Madhuri Hegde as VP and chief scientific officer for its newly created Laboratory Services group. In this role, Hegde will oversee the laboratory services group to ensure the delivery of innovative solution to clinical and healthcare system customers, the company said. She joins PerkinElmer from Emory Genetics Lab where she served as chief scientific officer and executive director.


Herman Verrelst

Biocartis has appointed Herman Verrelst as its new CEO, effective as of August. Verrelst currently holds the position of VP and general manager of the genomics and clinical applications division of Agilent Technologies. He joined Agilent from Cartagenia, where he served as CEO and founder until its acquisition by Agilent. He also served as CEO of Medicim, which was acquired by Swiss-based Nobel Biocare, in addition to serving as CEO and founder of DATA4s, which was acquired by Norkom Technologies.


For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.